Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Functional significance of factor H binding to Neisseria meningitidis.

Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, Sim RB, Tang CM.

J Immunol. 2006 Jun 15;176(12):7566-75.

2.

Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum.

Friberg N, Carlson P, Kentala E, Mattila PS, Kuusela P, Meri S, Jarva H.

J Immunol. 2008 Dec 15;181(12):8624-32.

3.

Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion.

Ngampasutadol J, Ram S, Gulati S, Agarwal S, Li C, Visintin A, Monks B, Madico G, Rice PA.

J Immunol. 2008 Mar 1;180(5):3426-35.

4.

The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, Ngampasutadol J, Vogel U, Granoff DM, Ram S.

J Immunol. 2006 Jul 1;177(1):501-10.

5.
6.

Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies.

Seib KL, Brunelli B, Brogioni B, Palumbo E, Bambini S, Muzzi A, DiMarcello F, Marchi S, van der Ende A, Aricó B, Savino S, Scarselli M, Comanducci M, Rappuoli R, Giuliani MM, Pizza M.

Infect Immun. 2011 Feb;79(2):970-81. doi: 10.1128/IAI.00891-10. Epub 2010 Dec 13.

7.
8.

The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.

Ram S, Mackinnon FG, Gulati S, McQuillen DP, Vogel U, Frosch M, Elkins C, Guttormsen HK, Wetzler LM, Oppermann M, Pangburn MK, Rice PA.

Mol Immunol. 1999 Sep-Oct;36(13-14):915-28. Review.

PMID:
10698346
9.

Haemophilus influenzae interacts with the human complement inhibitor factor H.

Hallström T, Zipfel PF, Blom AM, Lauer N, Forsgren A, Riesbeck K.

J Immunol. 2008 Jul 1;181(1):537-45.

11.

Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis.

Jarva H, Ram S, Vogel U, Blom AM, Meri S.

J Immunol. 2005 May 15;174(10):6299-307.

12.
13.

Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.

Vogel U, Weinberger A, Frank R, Müller A, Köhl J, Atkinson JP, Frosch M.

Infect Immun. 1997 Oct;65(10):4022-9.

14.

Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin.

Madico G, Ngampasutadol J, Gulati S, Vogel U, Rice PA, Ram S.

J Immunol. 2007 Apr 1;178(7):4489-97.

15.

Characterization of complement factor H binding to Yersinia enterocolitica serotype O:3.

Biedzka-Sarek M, Jarva H, Hyytiäinen H, Meri S, Skurnik M.

Infect Immun. 2008 Sep;76(9):4100-9. doi: 10.1128/IAI.00313-08. Epub 2008 Jul 14.

16.

Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.

Lewis LA, Vu DM, Vasudhev S, Shaughnessy J, Granoff DM, Ram S.

MBio. 2013 Oct 15;4(5):e00339-13. doi: 10.1128/mBio.00339-13.

17.

Functional impacts of the diversity of the meningococcal factor H binding protein.

Hong E, Giorgini D, Deghmane AE, Taha MK.

Vaccine. 2012 Dec 17;31(1):183-9. doi: 10.1016/j.vaccine.2012.10.072. Epub 2012 Oct 30.

PMID:
23123023
18.

Human complement factor H binds to outer membrane protein Rck of Salmonella.

Ho DK, Jarva H, Meri S.

J Immunol. 2010 Aug 1;185(3):1763-9. doi: 10.4049/jimmunol.1001244. Epub 2010 Jul 9.

19.

Interactions between Neisseria meningitidis and the complement system.

Schneider MC, Exley RM, Ram S, Sim RB, Tang CM.

Trends Microbiol. 2007 May;15(5):233-40. Epub 2007 Mar 29. Review.

PMID:
17398100

Supplemental Content

Support Center